Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 4Brain Neoplasms 4Glioma 3Glioblastoma 3Carcinoma, Hepatocellular 3Neoplasms 2Head and Neck Neoplasms 2Skin Neoplasms 1Sarcoma 1Neoplasm Metastasis 1Meningioma 1Melanoma 1Liver Cirrhosis 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Astrocytoma 1

Interventions

Magnetic Resonance Spectroscopy 12gallium Ga 68 dotatate 6Everolimus 6lutetium Lu 177 dotatate 5Radiosurgery 5Proton Therapy 5Bevacizumab 5pembrolizumab 4Surveys and Questionnaires 4Specimen Handling 4Hydroxyurea 4abemaciclib 3Tranexamic Acid 3Surgical Procedures, Operative 3Sodium Chloride 3Ga(III)-DOTATOC 32-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3vistusertib 2trametinib 2ribociclib 2arginyllysine 2aldesleukin 2Yoga 2Whole Body Imaging 2Sunitinib 2Saline Solution 2Ropivacaine 2Radiotherapy 2Protons 2Observation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Meningioma × fluoromisonidazole × Clear all
NCT01246869 2024-10-01

Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water

University of Utah

Phase 1 Terminated
2 enrolled
CNS

Brain Neoplasms, Glioblastoma, Glioma, Meningioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡